These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19881346)

  • 1. New insights into the mechanisms controlling neutrophil survival.
    Cabrini M; Nahmod K; Geffner J
    Curr Opin Hematol; 2010 Jan; 17(1):31-5. PubMed ID: 19881346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive neutrophil apoptosis: mechanisms and regulation.
    Luo HR; Loison F
    Am J Hematol; 2008 Apr; 83(4):288-95. PubMed ID: 17924549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor and trail interactions in epithelial-derived cells.
    Gibson SB
    Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators.
    Lee A; Whyte MK; Haslett C
    J Leukoc Biol; 1993 Oct; 54(4):283-8. PubMed ID: 8409750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between extrinsic and intrinsic cell death pathways in pancreatic cancer: synergistic action of estrogen metabolite and ligands of death receptor family.
    Basu A; Castle VP; Bouziane M; Bhalla K; Haldar S
    Cancer Res; 2006 Apr; 66(8):4309-18. PubMed ID: 16618756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.
    Schulte-Hermann R; Bursch W; Marian B; Grasl-Kraupp B
    IARC Sci Publ; 1999; (146):273-85. PubMed ID: 10353391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways.
    Berg D; Stühmer T; Siegmund D; Müller N; Giner T; Dittrich-Breiholz O; Kracht M; Bargou R; Wajant H
    FEBS J; 2009 Dec; 276(23):6912-27. PubMed ID: 19895579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene profiling of in vitro and in vivo models of delayed neutrophil apoptosis: a common pathway?
    O'Neill A; Greenan MC; Doyle B; Fitzpatrick JM; Watson RW
    Biochem Soc Trans; 2004 Jun; 32(Pt3):470-3. PubMed ID: 15157163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAIL and apoptosis induction by TNF-family death receptors.
    Wang S; El-Deiry WS
    Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF; Erff M; Ashkenazi A
    Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential].
    Busso V; Smirne C; Ferrero I; Segir R; Abrate S; Bellone G; Emanuelli G
    Minerva Med; 2001 Apr; 92(2):99-111. PubMed ID: 11323572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting death receptors in bladder, prostate and renal cancer.
    O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
    J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
    Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
    Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More than one way to die: apoptosis, necrosis and reactive oxygen damage.
    Fiers W; Beyaert R; Declercq W; Vandenabeele P
    Oncogene; 1999 Dec; 18(54):7719-30. PubMed ID: 10618712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.